PhenoSwitch Bioscience
PhenoSwitch Bioscience is a Canadian contract research organization founded in 2013 that delivers mass spectrometry-based analytical services to biotechnology and pharmaceutical clients.
- Company typePrivate
- Founded2013
- HeadquartersSherbrooke, Canada
- Headcount11–50
- GTM typeB2B
- OfferingServices
What PhenoSwitch Bioscience does
PhenoSwitch Bioscience is a contract research organization (CRO) that provides mass spectrometry-based analytical services to biotechnology and pharmaceutical clients. The firm was founded in 2013 and is headquartered in Sherbrooke, Quebec, Canada, with operations supported by a headcount in the 11–50 employee range. Its core offering centers on mass spectrometry workflows applied to client R&D samples, positioning it as a specialty analytical services provider rather than a product or platform vendor. No product catalog, pricing model, customer logos, or named service lines are disclosed in the source data, indicating a relatively low public profile for a niche-services CRO.
The underlying technology stack is not detailed in the available data, but the stated service category implies capabilities across small-molecule, proteomic, metabolomic, or biomarker mass spectrometry workflows depending on client need. No proprietary software, AI/ML components, APIs, or integrations are referenced — the api_details record explicitly confirms no public API. The firm appears to monetize through project-based or contract research engagements with biotech and pharma groups, though contract values, pricing models, and segment mix are not disclosed. The disclosed leadership is limited to a single named director, Kent MacLean, suggesting a lean management footprint consistent with a small specialty CRO.
The overall information density around PhenoSwitch Bioscience is low: no funding rounds, partnerships, certifications, patents, awards, or geographic expansion signals are recorded. The company's competitive position, customer concentration, and revenue trajectory cannot be triangulated from public sources in the provided dataset.
PhenoSwitch Bioscience firmographics
Firmographics- Name
- PhenoSwitch Bioscience
- Website
- https://phenoswitchbioscience.com
- Company type
- Private
- Founded year
- 2013
- Headcount range
- 11–50 employees
- Short description
- PhenoSwitch Bioscience is a Canadian contract research organization founded in 2013 that delivers mass spectrometry-based analytical services to biotechnology and pharmaceutical clients.
- Ownership category
- akta.pro rank
PhenoSwitch Bioscience industry classification
Industry- Product category
- Contract Research Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Proteomics & Mass Spectrometry Services (HLAGANAB)
- akta.pro secondary industry
- Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD)
Keywords
Where PhenoSwitch Bioscience is headquartered
LocationHeadquarters
- HQ city
- Sherbrooke
- HQ country
- Canada
- HQ region
- North America
Markets served
PhenoSwitch Bioscience business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure
PhenoSwitch Bioscience product offering
Product offeringCore offering
PhenoSwitch Bioscience is a contract research organization that provides mass spectrometry services to biotechnology and pharmaceutical groups. The company delivers analytical and research support to drug development and life sciences clients from its base in Sherbrooke, Canada.
Differentiator
Problem solved
Functional benefit
Products and services
- Mass Spectrometry Services
Companies that use PhenoSwitch Bioscience
Customer profileIdeal customer profiles1 record
PhenoSwitch Bioscience technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
PhenoSwitch Bioscience partnerships and signals
Strategic signalRecent moves1 record
PhenoSwitch Bioscience competitors and assessment
Company assessmentDirect peers
- Biognosys: Swiss proteomics CRO providing mass spectrometry-based discovery and targeted proteomics services to global pharma. Direct competitor in high-end MS-based proteomics services with overlapping client profile (biopharma sponsors).
- Proteome Sciences: UK-based CRO offering mass spectrometry-based proteomics and biomarker services to pharma and biotech. Closely comparable as a specialty MS-services provider with the same sponsor mix and scientific positioning as PhenoSwitch.
Broad incumbents
- WuXi AppTec: Chinese-headquartered global CRO/CDMO with substantial bioanalytical and MS capabilities serving pharma R&D. Significant competitor for bioanalytical work, particularly where sponsors seek lower-cost offshore capacity.
- Charles River Laboratories: Global CRO providing bioanalytical, LC-MS/MS and biomarker services as part of a larger portfolio including safety assessment and manufacturing. Offers overlapping MS-capability but at greater scale and with broader service bundling.
- Labcorp Drug Development: Full-service global CRO with large-scale bioanalytical and central laboratory MS capabilities supporting clinical trials. Competes for higher-volume, integrated work that PhenoSwitch cannot serve as a specialty provider.
- Eurofins Scientific: Global testing-services group with extensive mass spectrometry and bioanalytical capacity across pharma, food, and environmental testing. Adjacent space but its pharma-focused service lines compete with specialty MS CROs.
- SGS Life Sciences: Global CRO with bioanalytical and MS-based services for clinical and preclinical studies. Competes on bioanalytical work within a much broader inspection, testing, and certification portfolio.
Emerging players
- MRM Proteomics: Canadian (Vancouver) specialty CRO offering SRM/MRM-based targeted proteomics and quantitative mass spectrometry services to academic and biopharma clients. Geographic and technical overlap with PhenoSwitch.
- Bionova Scientific: US-based biopharma services provider offering analytical and MS-based characterization for biologics and gene therapies. Comparable as an emerging specialty MS-services player targeting the same biopharma segment.
- Protein Metrics: US-based vendor of mass spectrometry software and analytical services for biopharma, with growing focus on biotherapeutic characterization. Overlaps with PhenoSwitch in delivering MS-based analytical solutions to pharma R&D.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key highlights5 records
Customer concentration
PhenoSwitch Bioscience social profiles
Digital presencePhenoSwitch Bioscience financial estimates
Financial estimateRevenue estimate
Valuation estimate
PhenoSwitch Bioscience leadership team
Management profileNumber of profiles
Profiles1 record
PhenoSwitch Bioscience funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PhenoSwitch Bioscience M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PhenoSwitch Bioscience
What does PhenoSwitch Bioscience do?
PhenoSwitch Bioscience is a contract research organization that provides mass spectrometry services to biotechnology and pharmaceutical groups. The company delivers analytical and research support to drug development and life sciences clients from its base in Sherbrooke, Canada.
When was PhenoSwitch Bioscience founded?
PhenoSwitch Bioscience was founded in 2013. It employs 11 to 50 people.
Where is PhenoSwitch Bioscience based?
PhenoSwitch Bioscience is headquartered in Sherbrooke, Canada, in the North America region.
Who are PhenoSwitch Bioscience's main competitors?
Direct peers on record are Biognosys and Proteome Sciences. Broad incumbents are WuXi AppTec, Charles River Laboratories, Labcorp Drug Development, Eurofins Scientific and SGS Life Sciences. Emerging players are MRM Proteomics, Bionova Scientific and Protein Metrics.
Does PhenoSwitch Bioscience have an API?
No public API is recorded for PhenoSwitch Bioscience.
What industry is PhenoSwitch Bioscience in?
PhenoSwitch Bioscience's product category is Contract Research Services. Its primary akta.pro industry code is HLAGANAB, Proteomics & Mass Spectrometry Services, with a secondary code of HLAGAAAD, Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity). Its NAICS code is 5417 and its SIC code is 8731.